Who we are
ImmSilico is a consultancy at the forefront of tissue immunity and technological innovation. We combine scientific depth with cutting‑edge AI and experimental technology to address real‑world immunology challenges.
Mission & Vision
We empower discovery in immunology by integrating advanced experimental platforms with cutting-edge AI. Our goal: help research teams make smarter choices, turn complex data into actionable insight, and accelerate breakthroughs in tissue immunity and clinical translation.
We help teams make strategic decisions — from selecting emerging platforms like single-cell or spatial omics to interpreting complex immune data with state-of-the-art analytical tools. Through tailored consulting, we accelerate innovation in tissue immunity research and clinical translation.
We envision a future where every immunology researcher can confidently navigate both the experimental and computational landscape. Whether designing your first spatial multi-omic study or optimising T cell data integration, we guide you through the what, why, and how — ensuring your platforms fit your scientific question and deliver meaningful results.
Our vision is to make experimental clarity and data intelligence accessible to every lab, unlocking the immune system’s secrets and enabling discoveries with real-world impact.
The Core Team
-
Prof Hashem Koohy
Director | Co-founder | Systems T Cell Immunologist & AI Strategist
Hashem leads a Systems Immunology group at the University of Oxford. With research interests at the intersection of immunology and AI, he contributes to unravelling the fundamental principles of T cell immunity. Drawing on 15+ years of research experience, he co‑founded ImmSilico to decode and design immunity through AI and advanced technologies.
-
Dr Agne Anatanviciute
Co-founder | Spatial Tissue Immunology & Experimental Technology Strategist
Agne leads a cutting‑edge research group at the forefront of single‑cell and spatial technologies. With a strong track record of aligning advanced experimental platforms to complex immunological questions, she drives discovery in tissue immunity through innovation, precision, and methodological excellence.
-
Dr David Fawkner-Corbett
Co-founder | Clinician & Experimental Technology Strategist
David is an NIHR Academic Clinical Lecturer in Paediatric Surgery at the University of Oxford. His work integrates clinical practice with scientific research, focusing on human intestinal development, maturation, and disease. He has extensive expertise in single‑cell RNA sequencing and multiple spatial platforms. From project planning to experimental innovation, he drives large‑scale multi‑omic studies that advance understanding and therapeutic discovery.
Our Network of Expertise
At ImmSilico, our core team is supported by a growing network of associate consultants—seasoned experts at the cutting edge of tissue immunity and technology.
Our associates bring expertise across experimental immunology, humoral and cellular immunity, spatial and single‑cell platforms, and AI‑driven analytics — enabling us to tailor teams for each project’s unique challenges.
This collaborative model ensures we bring the right expertise to the right problem, delivering deep insight from bench to data to therapy.
Join the ImmSilico Collective
Are you an expert in tissue immunity, experimental platforms, or AI for biomedical research?
We’re always looking to collaborate with exceptional minds who combine scientific depth with clear communication and a passion for innovation.
If you’re interested in joining our associate network, we’d love to hear from you.